These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
51. Pallidal neuronal apolipoprotein E in pantothenate kinase-associated neurodegeneration recapitulates ischemic injury to the globus pallidus. Woltjer RL; Reese LC; Richardson BE; Tran H; Green S; Pham T; Chalupsky M; Gabriel I; Light T; Sanford L; Jeong SY; Hamada J; Schwanemann LK; Rogers C; Gregory A; Hogarth P; Hayflick SJ Mol Genet Metab; 2015 Dec; 116(4):289-97. PubMed ID: 26547561 [TBL] [Abstract][Full Text] [Related]
52. Biochemical properties of human pantothenate kinase 2 isoforms and mutations linked to pantothenate kinase-associated neurodegeneration. Zhang YM; Rock CO; Jackowski S J Biol Chem; 2006 Jan; 281(1):107-14. PubMed ID: 16272150 [TBL] [Abstract][Full Text] [Related]
53. Genetic Characterization of Plasmodium Putative Pantothenate Kinase Genes Reveals Their Essential Role in Malaria Parasite Transmission to the Mosquito. Hart RJ; Cornillot E; Abraham A; Molina E; Nation CS; Ben Mamoun C; Aly AS Sci Rep; 2016 Sep; 6():33518. PubMed ID: 27644319 [TBL] [Abstract][Full Text] [Related]
54. Excess coenzyme A reduces skeletal muscle performance and strength in mice overexpressing human PANK2. Corbin DR; Rehg JE; Shepherd DL; Stoilov P; Percifield RJ; Horner L; Frase S; Zhang YM; Rock CO; Hollander JM; Jackowski S; Leonardi R Mol Genet Metab; 2017 Apr; 120(4):350-362. PubMed ID: 28189602 [TBL] [Abstract][Full Text] [Related]
55. 4'-Phosphopantetheine corrects CoA, iron, and dopamine metabolic defects in mammalian models of PKAN. Jeong SY; Hogarth P; Placzek A; Gregory AM; Fox R; Zhen D; Hamada J; van der Zwaag M; Lambrechts R; Jin H; Nilsen A; Cobb J; Pham T; Gray N; Ralle M; Duffy M; Schwanemann L; Rai P; Freed A; Wakeman K; Woltjer RL; Sibon OC; Hayflick SJ EMBO Mol Med; 2019 Dec; 11(12):e10489. PubMed ID: 31660701 [TBL] [Abstract][Full Text] [Related]
57. A novel gene mutation in PANK2 in a patient with an atypical form of pantothenate kinase-associated neurodegeneration. Pérez-González EA; Chacón-Camacho OF; Arteaga-Vázquez J; Zenteno JC; Mutchinick OM Eur J Med Genet; 2013 Nov; 56(11):606-8. PubMed ID: 24075960 [TBL] [Abstract][Full Text] [Related]
58. Clinical and genetic features of PKAN patients in a tertiary centre in Turkey. Akcakaya NH; Iseri SU; Bilir B; Battaloglu E; Tekturk P; Gultekin M; Akar G; Yigiter R; Hanagasi H; Alp R; Cagirici S; Eraksoy M; Ozbek U; Yapici Z Clin Neurol Neurosurg; 2017 Mar; 154():34-42. PubMed ID: 28113101 [TBL] [Abstract][Full Text] [Related]
59. Pantothenate-kinase associated neurodegeneration (PKAN) "eye of the tiger" sign. Renaud DL; Kotagal S Pediatr Neurol; 2007 Jan; 36(1):70-1. PubMed ID: 17162204 [No Abstract] [Full Text] [Related]
60. The diverse phenotype and genotype of pantothenate kinase-associated neurodegeneration. Pellecchia MT; Valente EM; Cif L; Salvi S; Albanese A; Scarano V; Bonuccelli U; Bentivoglio AR; D'Amico A; Marelli C; Di Giorgio A; Coubes P; Barone P; Dallapiccola B Neurology; 2005 May; 64(10):1810-2. PubMed ID: 15911822 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]